GenSight Biologics S.A. (GSGTF)
GSGTF Stock Price Chart
Explore GenSight Biologics S.A. interactive price chart. Choose custom timeframes to analyze GSGTF price movements and trends.
GSGTF Company Profile
Discover essential business fundamentals and corporate details for GenSight Biologics S.A. (GSGTF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
22 Jan 2018
Employees
16.00
CEO
Laurence Rodriguez
Description
GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, as well as in preclinical stage to treat dry age-related macular degeneration. The company also develops products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. GenSight Biologics S.A. was incorporated in 2012 and is headquartered in Paris, France.
GSGTF Financial Timeline
Browse a chronological timeline of GenSight Biologics S.A. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 21 Jan 2026
Upcoming earnings on 19 Sept 2025
Earnings released on 13 May 2025
EPS came in at -$0.10 , while revenue for the quarter reached -$228.00K .
Earnings released on 24 Oct 2024
EPS came in at -$0.07 , while revenue for the quarter reached $1.73M .
Earnings released on 29 May 2024
EPS came in at -$0.28 , while revenue for the quarter reached $248.00K .
Earnings released on 30 Jun 2023
EPS came in at -$0.26 , while revenue for the quarter reached $1.55M .
Earnings released on 24 Mar 2023
EPS came in at -$0.36 , while revenue for the quarter reached $614.00K .
Earnings released on 28 Oct 2022
EPS came in at -$0.23 , while revenue for the quarter reached $3.06M .
Earnings released on 21 Apr 2022
EPS came in at -$0.44 , while revenue for the quarter reached $828.00K .
Earnings released on 10 Nov 2021
EPS came in at -$0.19 , while revenue for the quarter reached $5.57M .
Earnings released on 10 Mar 2021
EPS came in at -$0.54 , while revenue for the quarter reached $3.69M .
GSGTF Stock Performance
Access detailed GSGTF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.